Innovative Biosensor Platforms for the Detection of Metformin in Diabetes Management
Abstract
Metformin, a widely prescribed antihyperglycemic agent, plays a crucial role in the management of Type 2 diabetes by reducing hepatic glucose production and increasing insulin sensitivity. Its effectiveness in glucose regulation has made it a cornerstone in diabetes care, necessitating precise monitoring of drug levels to optimize therapeutic outcomes and minimize potential adverse effects. This review explores contemporary biosensor technologies designed for the sensitive detection of metformin, emphasizing their significance in clinical and pharmaceutical settings. We analyze various biosensor platforms, including electrochemical, optical, and piezoelectric systems, highlighting their principles, advantages, and challenges. Additionally, we discuss the integration of nanomaterials to enhance detection sensitivity and specificity. Given the rising prevalence of diabetes globally, the development of innovative biosensing strategies for metformin detection is paramount in ensuring effective patient management and improving treatment adherence. The insights gained from this review aim to propel further research and development in this vital area of biomedical engineering.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.